Mittal Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-11-2024
- Paid Up Capital ₹ 1.50 M
as on 15-11-2024
- Company Age 28 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.01 Cr
as on 15-11-2024
- Satisfied Charges ₹ 2.83 Cr
as on 15-11-2024
- Revenue 1.45%
(FY 2023)
- Profit 0.73%
(FY 2023)
- Ebitda 22.63%
(FY 2023)
- Net Worth 12.93%
(FY 2023)
- Total Assets 5.14%
(FY 2023)
About Mittal Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹5.01 Cr. The company has closed loans amounting to ₹2.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Gupta, Ravindra Gupta, and Arpan Gupta serve as directors at the Company.
- CIN/LLPIN
U24232RJ1996PTC013061
- Company No.
013061
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mittal Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Gupta  | Director | 24-Mar-2004 | Current |
| Ravindra Gupta | Director | 31-Dec-1996 | Current |
| Arpan Gupta | Director | 31-Mar-2001 | Current |
Financial Performance of Mittal Pharma.
Mittal Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.45% increase. The company also saw a slight improvement in profitability, with a 0.73% increase in profit. The company's net worth Soared by an impressive increase of 12.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mittal Pharma?
In 2023, Mittal Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Salasar Balaji Buildhome Private LimitedActive 20 years 3 monthsJyoti Gupta and Ravindra Gupta are mutual person
- Shri Shyamkripa Properties Private LimitedActive 19 years 8 months
Jyoti Gupta and Ravindra Gupta are mutual person
- Lotus Ashiana Township Private LimitedActive 19 years 7 months
Jyoti Gupta and Ravindra Gupta are mutual person
- Pashupati Buildhome Private LimitedActive 19 years 4 months
Jyoti Gupta and Ravindra Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jun 2020 | ₹3.60 M | Open |
Others Creation Date: 25 Apr 2019 | ₹4.65 Cr | Open |
Others Creation Date: 05 Jul 2017 | ₹6.80 M | Satisfied |
How Many Employees Work at Mittal Pharma?
Unlock and access historical data on people associated with Mittal Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mittal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mittal Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
